source
- Immunotherapy trials like PODIUM-303 are reshaping treatment for squamous cell anal cancer, says Dr ParikhDr Aparna R. Parikh, an oncologist at Massachusetts General Hospital and Harvard professor, highlighted the growing feasibility of immunotherapy studies in squamous cell anal carcinoma (SCAC). She…
- Capsida Biotherapeutics still unable to determine cause of child death in brain-targeted gene therapy trialCapsida Biotherapeutics reported that it still has no explanation for the death of a child who participated in its CAP-002 gene therapy trial last September. The trial was intended to test a new c…